Clinical trial shows stereotactic radiation extends systemic therapy and slows kidney cancer progression : Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2022/stereotactic-radiation-extends-systemic-therapy.html
A new study by the Kidney Cancer Program (KCP) at UT Southwestern’s Harold C.
Take action to prevent cervical cancer: Newsroom, UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2019/prevent-cervical-cancer.html
Almost all cases of cervical cancer are caused by human papillomavirus, or HPV, making it a preventable cancer, say UT Southwestern Medical Center physicians.
Cancer-fighting gene restrains 'jumping genes' : Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2020/cancer-fighting-gene-restrains-jumping-genes.html
Now, UT Southwestern scientists have discovered a new role for p53 in its fight against tumors: preventing retrotransposons, or “jumping genes,” from hopping around the human genome.
Most pancreatic cancer patients don’t get lifesaving surgery: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2023/july-pancreatic-cancer-patients.html
Only 22% of Texas patients with early-stage pancreatic cancer received standard-of-care surgery to remove their tumors, researchers at UT Southwestern Medical Center report in a new study.
Lung cancer researcher named Giant of Cancer Care: October 2015 News Releases - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2015/giant-cancer-care.html
Cancer biologist Dr. John Minna, with the Harold C. Simmons Comprehensive Cancer Center at UT Southwestern, has been named a “Giant of Cancer Care.”
$37 million CPRIT support includes funds for pediatric cancer database: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2018/cprit-cancer-detection.html
The Cancer Prevention and Research Institute of Texas (CPRIT) has awarded more than $37 million to UT Southwestern for cancer research and prevention.
UT Southwestern researchers’ work shines LIGHT on how to improve cancer immunotherapy
https://www.utsouthwestern.edu/newsroom/articles/year-2016/light-cancer-immunotherapy.html
UT Southwestern Medical Center researchers today report on a strategy to make a major advance in cancer treatment even better, and a means to test and refine this new type of immunotherapy.
UTSW study finds p53 gene plays second role in suppressing genes tied to cancer: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2022/august-p53-gene-plays-second-role.html
A gene that’s well known for its role in turning on tumor-suppressing genes when cells become stressed also keeps potential tumor-driving genes turned off, UT Southwestern researchers report in a new study.
UT Southwestern leads expert consortium refining prognosis of invasive kidney cancer: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2018/kidney-cancer-consortium.html
The nationally recognized Kidney Cancer Program at UT Southwestern Medical Center’s Harold C.
Mentoring the next generation of cancer researchers: November 2016 Features - UT Southwestern, Dallas, TX
https://www.utsouthwestern.edu/newsroom/articles/year-2016/cancer-researchers.html
David Gerber, M.D., Associate Professor of Internal Medicine at UT Southwestern Medical Center, knows the importance of mentorship and its role in advancing cancer research.